Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,250 | 1 | 44.1% |
| Food and Beverage | $1,307 | 20 | 25.6% |
| Travel and Lodging | $1,130 | 2 | 22.2% |
| Long term medical supply or device loan | $398.80 | 4 | 7.8% |
| Education | $11.92 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Heron Therapeutics, Inc. | $3,484 | 5 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $398.80 | 4 | $0 (2024) |
| Gilead Sciences, Inc. | $296.05 | 5 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $243.58 | 3 | $0 (2024) |
| Daiichi Sankyo Inc. | $144.20 | 2 | $0 (2024) |
| Lilly USA, LLC | $140.00 | 2 | $0 (2023) |
| Tempus AI, Inc | $120.90 | 2 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $108.54 | 2 | $0 (2020) |
| PFIZER INC. | $73.23 | 1 | $0 (2017) |
| Exelixis Inc. | $65.66 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $796.17 | 10 | Novartis Pharmaceuticals Corporation ($398.80) |
| 2023 | $333.95 | 3 | Lilly USA, LLC ($125.00) |
| 2022 | $110.86 | 1 | Gilead Sciences, Inc. ($110.86) |
| 2021 | $11.92 | 1 | Gilead Sciences, Inc. ($11.92) |
| 2020 | $90.41 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($90.41) |
| 2019 | $197.21 | 6 | Exelixis Inc. ($65.66) |
| 2017 | $3,557 | 6 | Heron Therapeutics, Inc. ($3,484) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 2 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2017 | Heron Therapeutics, Inc. | CINVANTI (Drug) | Travel and Lodging | In-kind items and services | $307.59 | General |
| Category: CINV | ||||||
| 11/11/2017 | Heron Therapeutics, Inc. | CINVANTI (Drug) | Food and Beverage | In-kind items and services | $58.00 | General |
| Category: CINV | ||||||
| 11/11/2017 | Heron Therapeutics, Inc. | CINVANTI (Drug) | Food and Beverage | In-kind items and services | $46.26 | General |
| Category: CINV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 148 | 213 | $40,088 | $18,128 |
| 2022 | 5 | 125 | 209 | $45,613 | $20,518 |
| 2021 | 5 | 131 | 233 | $46,931 | $21,773 |
| 2020 | 3 | 121 | 209 | $22,769 | $15,093 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 33 | 65 | $10,785 | $7,234 | 67.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 41 | 50 | $5,725 | $3,712 | 64.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 41 | $9,348 | $2,631 | 28.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 16 | $6,912 | $1,696 | 24.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 22 | 22 | $5,038 | $1,436 | 28.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 19 | $2,280 | $1,419 | 62.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 26 | 57 | $9,585 | $6,393 | 66.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 37 | 57 | $6,404 | $4,004 | 62.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 19 | 19 | $12,160 | $3,074 | 25.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 36 | $11,736 | $2,918 | 24.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 15 | 15 | $3,103 | $2,279 | 73.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 25 | $2,625 | $1,850 | 70.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 24 | 71 | $11,255 | $7,891 | 70.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 14 | 44 | $14,344 | $3,740 | 26.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 33 | 49 | $5,620 | $3,329 | 59.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 15 | 15 | $9,600 | $2,474 | 25.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 14 | 19 | $2,945 | $2,155 | 73.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 18 | $1,890 | $1,281 | 67.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 17 | 17 | $1,277 | $902.87 | 70.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 39 | 79 | $10,085 | $6,849 | 67.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 54 | 92 | $8,568 | $5,801 | 67.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 17 | 26 | $3,033 | $1,720 | 56.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 12 | $1,083 | $723.09 | 66.8% |
About Dr. Randa Loutfi, M.D
Dr. Randa Loutfi, M.D is a Medical Oncology healthcare provider based in Detroit, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710055264.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Randa Loutfi, M.D has received a total of $5,098 in payments from pharmaceutical and medical device companies, with $796.17 received in 2024. These payments were reported across 28 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($2,250).
As a Medicare-enrolled provider, Loutfi has provided services to 525 Medicare beneficiaries, totaling 864 services with total Medicare billing of $75,512. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Medical Oncology
- Location Detroit, MI
- Active Since 12/01/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1710055264
Products in Payments
- CINVANTI (Drug) $3,484
- KISQALI (Drug) $398.80
- Trodelvy (Drug) $226.48
- Enhertu (Drug) $144.20
- VERZENIO (Drug) $125.00
- NINLARO (Drug) $108.54
- IBRANCE (Drug) $73.23
- Cabometyx (Drug) $65.66
- IMFINZI (Drug) $40.65
- Zydelig (Drug) $34.98
- Xofigo (Drug) $22.79
- ALIMTA (Drug) $15.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Detroit
Dr. Ahmed Kaseb, Md, MD
Medical Oncology — Payments: $183,915
Haythem Ali, M.d, M.D
Medical Oncology — Payments: $45,327
Clara Hwang, M.d, M.D
Medical Oncology — Payments: $13,347
Maria Levitin, M.d, M.D
Medical Oncology — Payments: $257.34
Gerold Bepler, Md, MD
Medical Oncology
Ira Wollner, M.d, M.D
Medical Oncology